Linked Data API

Show Search Form

Search Results

1385182
registered interest false more like this
date less than 2021-12-06more like thismore than 2021-12-06
answering body
Foreign, Commonwealth and Development Office more like this
answering dept id 208 more like this
answering dept short name Foreign, Commonwealth and Development Office more like this
answering dept sort name Foreign, Commonwealth and Development Office more like this
hansard heading Iraq: Turkey more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what assessment they have made of allegations that the government of Turkey is deploying chemical weapons in northern Iraq; and what plans they have to support an independent inquiry into their deployment by the Organisation for the Prohibition of Chemical Weapons. more like this
tabling member printed
Baroness Hodgson of Abinger more like this
uin HL4711 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-12-20more like thismore than 2021-12-20
answer text <p>The United Kingdom opposes the use of chemical weapons in all circumstances. We take any credible evidence of the use of chemical weapons very seriously. We have been monitoring the recent allegations of chemical weapons use in northern Iraq but the allegations remain unsubstantiated. Any evidence should be shared with States Parties to the Chemical Weapons Convention and provided through appropriate channels to the Organisation for the Prohibition of Chemical Weapons (OPCW) Technical Secretariat.</p> more like this
answering member printed Lord Ahmad of Wimbledon more like this
question first answered
less than 2021-12-20T12:42:49.22Zmore like thismore than 2021-12-20T12:42:49.22Z
answering member
4210
label Biography information for Lord Ahmad of Wimbledon more like this
tabling member
4301
label Biography information for Baroness Hodgson of Abinger remove filter
1385183
registered interest false more like this
date less than 2021-12-06more like thismore than 2021-12-06
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Strokes: Females more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what assessment they have made of reports of cerebral haemorrhage in UK women (1) below 60, and (2) 60 and above, and their link to the (a) Astra Zeneca COVID-19 vaccination, and (b) Pfizer COVID-19 vaccination. more like this
tabling member printed
Baroness Hodgson of Abinger more like this
uin HL4712 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-12-16more like thismore than 2021-12-16
answer text <p>The Medicines and Healthcare products Regulatory Agency has monitored suspected reports of cerebral haemorrhage and thrombosis following COVID-19 vaccination. No direct association between reports of cerebral haemorrhage and the AstraZeneca or Pfizer COVID-19 vaccines has been identified in women or men aged either above or below 60 years old. However, a review of reports of specific types of blood clot in cerebral veins, occurring with low platelets concluded that a link with AstraZeneca vaccine is likely. Cerebral hemorrhage may occur because of these events. No link has been identified with the Pfizer vaccine.</p><p>There is some evidence that the reported incidence rate of these blood clots is slightly higher in females compared to men, although this is not seen across all age groups. A higher reported incidence rate is seen in younger adult age groups following the first dose compared to the older groups at 21.1 per million doses in those aged 18 to 49 years old and 11.0 per million doses in those aged 50 years old and over. There does not appear to be an increased risk following the second dose of the AstraZeneca vaccine. The advice remains that the benefits of the COVID-19 vaccines outweigh the risks for the majority of people.</p>
answering member printed Lord Kamall more like this
question first answered
less than 2021-12-16T15:21:22.367Zmore like thismore than 2021-12-16T15:21:22.367Z
answering member
4909
label Biography information for Lord Kamall more like this
tabling member
4301
label Biography information for Baroness Hodgson of Abinger remove filter
1385184
registered interest false more like this
date less than 2021-12-06more like thismore than 2021-12-06
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Coronavirus: Vaccination more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government whether housebound patients are receiving COVID-19 vaccinations in the same timeframe as those who are able to visit vaccination centres in person; and, if not, what is the average delay. more like this
tabling member printed
Baroness Hodgson of Abinger more like this
uin HL4713 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2022-01-05more like thismore than 2022-01-05
answer text <p>The information is not held centrally in the format requested.</p> more like this
answering member printed Lord Kamall more like this
question first answered
less than 2022-01-05T11:38:38.807Zmore like thismore than 2022-01-05T11:38:38.807Z
answering member
4909
label Biography information for Lord Kamall more like this
tabling member
4301
label Biography information for Baroness Hodgson of Abinger remove filter